Novartis’s Vaccine Menveo Meets Goals in Protecting Infants From Meningitis
The results of a late-stage trial show Menveo could offer protection against meningitis — an infection of the brain and spinal cord. Now, the drugmaker intends to file Menveo for use in infants in the U.S. and Europe.
…